‘NRG-BR002: A Phase IIR/III Trial of Standard of Care Therapy with or without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer’ of page ‘NRG-BR002’
NRG-BR001 and NRG-BR002 PowerPoint Presentation Principal Investigator/Co-Principal Investigator Steven Chmura, MD, PhD Julia R. White, MD Primary Objective Phase II-R: To determine whether ablation (through SBRT and/or surgical resection of all known metastases) in oligometastatic breast cancer patients provides a sufficient signal for improved progression-free survival (PFS) to warrant full accrual to the Phase III […]
Read More